Needles Market – Overview, Growth Opportunities 2017-2025
Major factor driving growth of the needles market is increasing demand for vaccines, globally to prevent various diseases such as measles, rubella and hepatitis B. According to World Health Organization (WHO) 2018, globally around 86% of infants are vaccinated against 26 diseases, however, 19.5 million children unvaccinated leading to death of 2-3 million children each year. Human papilloma virus causes cervical cancer and around 280,000 women died from cervical cancer in 2015 globally, which led to introduction of vaccine to prevent cervical cancer, in turn positively affecting needles market. Introduction of stringent guidelines for safe injection practices is expected to aid in growth of the needles market. For instance, WHO issued safe injection practices and guidelines in 2010, for its member country. Also, Association of Professionals in Infection Control and Epidemiology in the U.S. issued updated guidelines in 2016 to prevent spread of infectious disease through unsafe injection practices.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1331
Needles are integral part of healthcare functions. Needles provide advantage over other routes of administration such as quick release of the drug in bodily fluids and instant relief for the patients. It has various applications ranging from surgical use to blood collection to drug administration. Needles such as safety needles are increasingly used in order to avoid needle stick injuries and infection. Needles such as pen needles are used by diabetic patients who need daily dose of insulin which is injected subcutaneously.
Growing geriatric population worldwide to drive growth of the global needles market
Rising geriatric population is expected to drive growth of the needles market. As per World Population Prospect, 2017 Revision report by United Nations in 2017, there were 962 million people, under the geriatric category (people aged 60 years and above). By 2030, this is projected to be 1.4 billion increasing at an annual rate of 3%. Geriatric people require frequent hospitalizations due to aging-associated diseases such as heart disease, stroke, diabetes and falling injuries. In certain cases, surgery is required which leads to hospitalization. This is expected to aid in growth of the market. Asia Pacific has a geriatric population of 547 million people, which is expected to reach 900 million geriatric population by 2025. Therefore, manufacturers could focus on expanding in this region. Also, stringent regulations related to safe injection practices by various governments is expected to propel demand for safety needles, in order to reduce chances of contamination from blood borne pathogens, for instance according to report published by WHO in 2014, up to 1.7 million people were infected with hepatitis B virus, up to 315 000 with hepatitis C virus and as many as 33 800 with HIV through an unsafe injection.
Key players are focusing on strategic mergers and acquisitions and development of innovative products, in order to enhance their market share. For instance, in September 2017, Becton, Dickinson and Company introduced BD Ultra-Fine micro pen needle for use with different pen injection devices, for people with diabetes, in order to reduce accidentally injection of insulin dose into a muscle and it provides one of shortest length pen needle. Nipro Medical Corporation launched ‘SafeTouch’ safety needle in 2016, which is known to protect the patients from needle stick injuries. Terumo Medical Corporation innovative product K-Pack Surshield launched in 2012 claims to be 20% sharper than its competitor and fits in all types’ syringes.
Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1331
Some of the key players operating in the global needles market are Becton, Dickinson and Company, Medtronic plc, Hamilton Company, Stryker Corporation, Terumo Corporation, B. Braun Melsungen AG, Boston Scientific Corporation, Nipro Medical Corporation, Novo Nordisk A/s, Thermo Fisher Scientific, and Smiths Medical.
You may be interested
Increasing funding in gene therapies is expected to fuel the growth of viral vectors and plasmid DNA manufacturing marketAlbert R - April 25, 2018
Gene therapy and genetically modified therapies are promising treatment option, which includes introduction of a normal or functional copy of a gene in the defective cell. Gene…
Increasing incidence of cancer is expected to fuel the growth of cancer metabolism based therapeutics marketAlbert R - April 25, 2018
According to the American Cancer Society (ACS), approximately 53,670 people are expected be diagnosed with pancreatic cancer and approximately 43,090 people are expected to die due to…
Innovation in technology to combat infectious diseases is expected to drive the future meningitis treatment marketAlbert R - April 25, 2018
Major driving factor for growth of the meningitis treatment market include the alliance of public and private sectors to increase availability of vaccine to the populace. For…